Literature DB >> 22546739

Cutaneous leishmaniasis in the dorsal skin of hamsters: a useful model for the screening of antileishmanial drugs.

Sara M Robledo1, Lina M Carrillo, Alejandro Daza, Adriana M Restrepo, Diana L Muñoz, Jairo Tobón, Javier D Murillo, Anderson López, Carolina Ríos, Carol V Mesa, Yulieth A Upegui, Alejandro Valencia-Tobón, Karina Mondragón-Shem, Berardo Rodríguez, Iván D Vélez.   

Abstract

Traditionally, hamsters are experimentally inoculated in the snout or the footpad. However in these sites an ulcer not always occurs, measurement of lesion size is a hard procedure and animals show difficulty to eat, breathe and move because of the lesion. In order to optimize the hamster model for cutaneous leishmaniasis, young adult male and female golden hamsters (Mesocricetus auratus) were injected intradermally at the dorsal skin with 1 to 1.5 x l0(7) promastigotes of Leishmania species and progression of subsequent lesions were evaluated for up to 16 weeks post infection. The golden hamster was selected because it is considered the adequate bio-model to evaluate drugs against Leishmania as they are susceptible to infection by different species. Cutaneous infection of hamsters results in chronic but controlled lesions, and a clinical evolution with signs similar to those observed in humans. Therefore, the establishment of the extent of infection by measuring the size of the lesion according to the area of indurations and ulcers is feasible. This approach has proven its versatility and easy management during inoculation, follow up and characterization of typical lesions (ulcers), application of treatments through different ways and obtaining of clinical samples after different treatments. By using this method the quality of animal life regarding locomotion, search for food and water, play and social activities is also preserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546739      PMCID: PMC3671841          DOI: 10.3791/3533

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  Failure of albendazole as an alternative treatment of cutaneous leishmaniasis in the hamster model.

Authors:  B Travi; Y Osorio
Journal:  Mem Inst Oswaldo Cruz       Date:  1998 Jul-Aug       Impact factor: 2.743

2.  The Kodak Ektachem dry layer technology for clinical chemistry.

Authors:  K M Reynolds
Journal:  Ups J Med Sci       Date:  1986       Impact factor: 2.384

Review 3.  Experimental models for leishmaniasis and for testing anti-leishmanial vaccines.

Authors:  M Hommel; C L Jaffe; B Travi; G Milon
Journal:  Ann Trop Med Parasitol       Date:  1995-12

4.  Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.

Authors:  Bruno L Travi; Yaneth Osorio; Peter C Melby; Bysani Chandrasekar; Lourdes Arteaga; Nancy G Saravia
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.

Authors:  E Handman; R Ceredig; G F Mitchell
Journal:  Aust J Exp Biol Med Sci       Date:  1979-02

6.  Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.

Authors:  Claudia M Espitia; Weiguo Zhao; Omar Saldarriaga; Yaneth Osorio; Lisa M Harrison; Michael Cappello; Bruno L Travi; Peter C Melby
Journal:  BMC Immunol       Date:  2010-06-22       Impact factor: 3.615

7.  The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis.

Authors:  Yaneth Osorio; Peter C Melby; Claude Pirmez; Bysani Chandrasekar; Nora Guarín; Bruno L Travi
Journal:  Parasite Immunol       Date:  2003-03       Impact factor: 2.280

8.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.

Authors:  R G Titus; M Marchand; T Boon; J A Louis
Journal:  Parasite Immunol       Date:  1985-09       Impact factor: 2.280

9.  Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters.

Authors:  W L Hanson; W L Chapman; V B Waits; J K Lovelace
Journal:  J Parasitol       Date:  1991-10       Impact factor: 1.276

10.  The inflammatory response promotes cutaneous metastasis in hamsters infected with Leishmania (Viannia) panamensis.

Authors:  B L Travi; Y Osorio; N G Saravia
Journal:  J Parasitol       Date:  1996-06       Impact factor: 1.276

View more
  7 in total

1.  In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis.

Authors:  Maritza Fernandez; Javier Murillo; Luz Amalia Ríos-Vásquez; Rogelio Ocampo-Cardona; David L Cedeño; Marjorie A Jones; Iván D Velez; Sara M Robledo
Journal:  Parasitol Res       Date:  2017-12-11       Impact factor: 2.289

2.  Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.

Authors:  Andrés Montoya; Alejandro Daza; Diana Muñoz; Karina Ríos; Viviana Taylor; David Cedeño; Iván D Vélez; Fernando Echeverri; Sara M Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

3.  Antileishmanial Effect of 5,3'-Hydroxy-7,4'-dimethoxyflavanone of Picramnia gracilis Tul. (Picramniaceae) Fruit: In Vitro and In Vivo Studies.

Authors:  Sara M Robledo; Wilson Cardona; Karen Ligardo; Jéssica Henao; Natalia Arbeláez; Andrés Montoya; Fernando Alzate; Juan M Pérez; Victor Arango; Iván D Vélez; Jairo Sáez
Journal:  Adv Pharmacol Sci       Date:  2015-04-30

4.  Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.

Authors:  Diana Caridha; Sandi Parriot; Thomas H Hudson; Thierry Lang; Franklyn Ngundam; Susan Leed; Jenell Sena; Michael Harris; Michael O'Neil; Richard Sciotti; Lisa Read; Herve Lecoeur; Mark Hickman; Max Grogl
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.

Authors:  Diana Caridha; Brian Vesely; Katrien van Bocxlaer; Byron Arana; Charles E Mowbray; Sima Rafati; Silvia Uliana; Rosa Reguera; Mara Kreishman-Deitrick; Richard Sciotti; Pierre Buffet; Simon L Croft
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-06-20       Impact factor: 4.077

6.  Therapeutic Efficacy of Arnica in Hamsters with Cutaneous Leishmaniasis Caused by Leishmania braziliensis and L. tropica.

Authors:  Sara M Robledo; Javier Murillo; Natalia Arbeláez; Andrés Montoya; Victoria Ospina; Franziska M Jürgens; Iván D Vélez; Thomas J Schmidt
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-22

7.  Estimation of Biological Parameters of Cutaneous Ulcers Caused by Leishmaniasis in an Animal Model Using Diffuse Reflectance Spectroscopy.

Authors:  Deivid Botina; Ricardo Franco; Javier Murillo; July Galeano; Artur Zarzycki; Maria C Torres-Madronero; Camilo Bermúdez; Jaime Montaño; Johnson Garzón; Franck Marzani; Sara M Robledo
Journal:  Sensors (Basel)       Date:  2019-10-28       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.